Clinical Trials Monitor
Section edited by Leisha A. Emens, MD, PhD
Reports on important new trial results; updates on new drug approvals and ongoing clinical studies; key perspectives on clinical issues and advances in the field relevant to the everyday use of cancer immunotherapy in the clinic. This section also aims to address trial design and analysis considerations that may be unique to cancer immunotherapy, and to provide guidance for implementing and managing the use of cancer immunotherapies in the clinic.
Official journal of
- Editorial Board
- Sign up for article alerts and news from this journal